Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/2000

Content (10 Articles)

Clinicopathological characteristics of breast carcinomas with allelic loss in the p73

Gemma Dominguez, Javier Silva, Jose M. Silva, Jose M. Garcia, Celia Miralles, Oscar Rodriguez, Eugenia Jareño, Mariano Provencio, Pilar España, Felix Bonilla

C-erbB-2 overexpression and survival in early onset breast cancer

Måns Agrup, Olle Stäl, Karen Olsen, Sten Wingren

A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society

Masakuni Noguchi, Kazuyoshi Motomura, Shigeru Imoto, Mitsuru Miyauchi, Kazuhiko Sato, Hiroji Iwata, Masatoshi Ohta, Masafumi Kurosumi, Koichirou Tsugawa

First experiences in screening women at high risk for breast cancer with MR imaging

Madeleine M.A. Tilanus-Linthorst, Inge Marie M. Obdeijn, Karina C.M. Bartels, Harry J. de Koning, Matthijs Oudkerk

Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer

Han-Sung Kang, Yeo-Kyu Youn, Seung-Keun Oh, Kuk Jin Choe, Dong-Young Noh

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine